178 related articles for article (PubMed ID: 2794753)
1. Elevated serum levels of soluble interleukin-2 receptors in HTLV-I--associated myelopathy.
Yamaguchi K; Nishimura Y; Kiyokawa T; Takatsuki K
J Lab Clin Med; 1989 Oct; 114(4):407-10. PubMed ID: 2794753
[TBL] [Abstract][Full Text] [Related]
2. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
3. Serum dehydroepiandrosterone and DHEA-sulfate in patients with adult T-cell leukemia and human T-lymphotropic virus type I carriers.
Uozumi K; Uematsu T; Otsuka M; Nakano S; Takatsuka Y; Iwahashi M; Hanada S; Arima T
Am J Hematol; 1996 Nov; 53(3):165-8. PubMed ID: 8895686
[TBL] [Abstract][Full Text] [Related]
4. [Natural history of HTLV-I infection].
Yamaguchi K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):770-4. PubMed ID: 1630039
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.
Manns A; Miley WJ; Wilks RJ; Morgan OS; Hanchard B; Wharfe G; Cranston B; Maloney E; Welles SL; Blattner WA; Waters D
J Infect Dis; 1999 Nov; 180(5):1487-93. PubMed ID: 10515807
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary involvement in patients with HTLV-I-associated myelopathy: increased soluble IL-2 receptors in bronchoalveolar lavage fluid.
Sugimoto M; Nakashima H; Matsumoto M; Uyama E; Ando M; Araki S
Am Rev Respir Dis; 1989 Jun; 139(6):1329-35. PubMed ID: 2786358
[TBL] [Abstract][Full Text] [Related]
7. [Human T-cell leukemia virus type I and adult T-cell leukemia-lymphoma].
Shimoyama M
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):589-600. PubMed ID: 2181940
[TBL] [Abstract][Full Text] [Related]
8. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of monocytosis and human monocytic colony-stimulating factor in patients with adult T-cell leukaemia/lymphoma.
Tokioka T; Shimamoto Y; Motoyoshi K; Yamaguchi M
Haematologia (Budap); 1994; 26(1):1-9. PubMed ID: 7959369
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia.
Fujiwara H; Arima N; Ohtsubo H; Matsumoto T; Kukita T; Kawada H; Imaizumi R; Ozaki A; Matsushita K; Tei C
Am J Hematol; 2002 Oct; 71(2):80-4. PubMed ID: 12353304
[TBL] [Abstract][Full Text] [Related]
11. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.
Kamihira S; Atogami S; Sohda H; Momita S; Yamada Y; Tomonaga M
Cancer; 1994 Jun; 73(11):2753-8. PubMed ID: 8194016
[TBL] [Abstract][Full Text] [Related]
12. Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Porto AF; Santos SB; Muniz AL; Basilio V; Rodrigues W; Neva FA; Dutra WO; Gollob KJ; Jacobson S; Carvalho EM
J Infect Dis; 2005 Feb; 191(4):612-8. PubMed ID: 15655786
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers.
Araki K; Harada K; Nakamoto K; Shiroma M; Miyakuni T
Clin Exp Immunol; 2000 Feb; 119(2):259-63. PubMed ID: 10632660
[TBL] [Abstract][Full Text] [Related]
14. Increased serum levels of C-terminal parathyroid hormone-related protein in different diseases associated with HTLV-1 infection.
Yamaguchi K; Kiyokawa T; Watanabe T; Ideta T; Asayama K; Mochizuki M; Blank A; Takatsuki K
Leukemia; 1994 Oct; 8(10):1708-11. PubMed ID: 7934167
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.
Tsukasaki K; Miller CW; Kubota T; Takeuchi S; Fujimoto T; Ikeda S; Tomonaga M; Koeffler HP
Cancer Res; 2001 May; 61(9):3770-4. PubMed ID: 11325850
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of soluble interleukin-2 receptor levels in the cerebrospinal fluid in patients with adult T-cell leukemia complicated with meningeal infiltration].
Tanaka K; Shiraishi K; Sakamoto A; Okubo Y; Fukuda Y; Fukahori S; Jojima H; Osabe S; Honda J; Natori H; Oizumi K
Gan To Kagaku Ryoho; 1996 Jun; 23(7):863-9. PubMed ID: 8678534
[TBL] [Abstract][Full Text] [Related]
17. Dermatological findings of human T lymphotropic virus type 1 (HTLV-I)-associated myelopathy/tropical spastic paraparesis.
Lenzi ME; Cuzzi-Maya T; Oliveira AL; Andrada-Serpa MJ; Araújo AQ
Clin Infect Dis; 2003 Feb; 36(4):507-13. PubMed ID: 12567310
[TBL] [Abstract][Full Text] [Related]
18. Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.
Shimizu Y; Takamori A; Utsunomiya A; Kurimura M; Yamano Y; Hishizawa M; Hasegawa A; Kondo F; Kurihara K; Harashima N; Watanabe T; Okamura J; Masuda T; Kannagi M
Cancer Sci; 2009 Mar; 100(3):481-9. PubMed ID: 19154412
[TBL] [Abstract][Full Text] [Related]
19. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
[TBL] [Abstract][Full Text] [Related]
20. Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals.
Saito M; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
J Neurol Sci; 2004 Apr; 219(1-2):157-61. PubMed ID: 15050452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
